June #180 : More Black Women Die From AIDS - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

The POZ Army: How We End AIDS Together

Criminal Injustice

From the Editor

Reignite the Fight

Feedback

Letters- June 2012

The POZ Q+A

Uncommon Threads

What You Need to Know

A Graduate Degree in Condoms

The Normal Heart on Tour

A Bang for Your Buck

The Odds May Not Be in Your Favor if You Don’t Know Your Status

Further Adventures in the Origin of AIDS

We Hear You

POZ Survey Says

What Will You Do to End AIDS?

What Matters to You

The Implementation of the Affordable Care Act

Treatment News

Chasing the Cure

More Black Women Die From AIDS

Can HIV-Positive People Get the Shingles Vax?

Drop Condoms on the Red Carpet, Not in Criminal Court

GMHC Treatment Issues June 2012

Comfort Zone

Mobile Health

POZ Heroes

The Artist

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

June 2012

More Black Women Die From AIDS

by Laura Whitehorn

In the United States, HIV-positive black women are twice as likely as their white counterparts to die of AIDS, according to the Women’s Interagency HIV Study (WIHS). Over 12 years, death rates among women on HIV meds were 16 percent among black women compared with 8.2 percent among white women. Worse treatment adherence among black women explained some—but not all—of the differences.

“There may be genetic differences in drug absorption,” Kathryn Anastos, MD, a WIHS principal investigator, says, “but we don’t really know yet. The data about how effective the drugs are, how well they help people with HIV stay healthy and alive, come predominantly from populations of European descent—mostly men.”

But Anastos adds, “We do know that these drugs work really well for most people, so the message is, be adherent to HIV treatment.”

Another message: We need more female- and race-specific clinical trials to determine how genes and gender affect HIV drug performance.

Search: black women, Women's Interagency HIV Study, WIHS, Kathryn Anastos

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    aqua_31206
    Macon
    Georgia


    newlife202
    JOLIET
    Illinois


    latinpozdallas
    Dallas
    Texas


    robert12
    Queens
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.